Advertisement
Screener

TVARDI THERAPEUTICS, INC. (TVRD) Finite-Lived Intangible Asset, Expected Amortization, Year One

TVARDI THERAPEUTICS, INC. Finite-Lived Intangible Asset, Expected Amortization, Year One

TVARDI THERAPEUTICS, INC. (TVRD) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $63.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-08-14

  • 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $63.00K.
  • 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $63.00K.
  • 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $63.00K.
  • 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $63.00K.
Period endFinite-Lived Intangible Asset, Expected Amortization, Year One
2026-06-30$63.00K
10-Q · filed 2026-08-14
2026-03-31$63.00K
10-Q · filed 2026-05-08
2025-12-31$63.00K
10-K · filed 2026-03-31
2025-09-30$63.00K
10-Q · filed 2025-11-13
2025-06-30$63.00K
10-Q · filed 2025-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36